BioCentury
ARTICLE | Financial News

Catabasis Pharmaceuticals proposes IPO

May 18, 2015 7:00 AM UTC

Catabasis Pharmaceuticals Inc., Cambridge, Mass. Business: Endocrine/Metabolic, Inflammation, Autoimmune Date announced: 2015-05-13 Type: IPO To be raised: Up to $75 million Shares: TBD Price: TBD Und...